Topic guide
Articles and reference material connected to this topic, organised for clear reading.
Reading path
Information in Investor’s Business Daily is for informational and educational purposes only and should not be construed as an offer, recommendation, solicitation, or rating to buy or sell securities. The infor…
Read guide →February 21, 2025 at 2:00 PM UTC Hims & Hers Health Inc. has acquired a California-based manufacturing facility to expand its range of peptide treatments, including those from weight loss to muscle recovery. O…
Read guide →Quartz April 17, 2026 The U.S. Food and Drug Administration set July 23–24 advisory meetings to evaluate seven peptides for compounding eligibility, a development with implications for telehealth and consumer …
Read guide →Photo by Innerbody Research As the telehealth landscape expands, you might find it hard to know which outlet will provide you with the best services. If you’re a man of just about any age, then Hims aims to be…
Read guide →One of the USA’s largest compounders, Hims & Hers, has announced the acquisition of a peptide facility in California. The acquisition will enable the company to strengthen the long-term durability of its domes…
Read guide →The acquisition will strengthen the long-term durability of the company’s domestic supply chain, helping to ensure Americans can consistently access personalized medications Hims & Hers Health, Inc., the leadi…
Read guide →